Editing Guideline: Screening for prostate cancer (Republic of Cyprus)

{{forproviders}} {{forpolicymakers}}
Go back to [[Republic of Cyprus]] page

'''Primary purpose:''' To outline the risk assessment and recommended procedures for PSA testing to detect prostate cancer.

'''Sponsor, manager or home institution:''' [[dataOwner::Ministry of Health]] and [[dataOwner:Health Insurance Organization]].

'''Type of information:''' This guideline provides risk percentages for prostate cancer based on PSA levels, along with screening recommendations considering age, race, family history, and other factors affecting PSA results. It also includes guidance on when to pursue further diagnostic procedures and highlights the importance of individualized patient-physician discussions. [[availableVariable::diagnosis]], [[availableVariable::medical procedures]], [[availableVariable::age]], [[availableVariable::screening]], [[availableVariable::check-up examinations]]. 

'''Cancer Areas of Interest:''' [[hasCancerType::C60-C63: Male genitalia cancer]]. [https://www.moh.gov.cy/moh/moh.nsf/bf38a2d2e174417cc225782600313992/3B7C3521A6E9A1BBC2257CF30028391C/$file/Προσυμπτωματικός%20έλεγχος%20για%20καρκίνο%20του%20προστάτη.pdf Click here to learn more].

'''Access to information:''' [https://www.moh.gov.cy/moh/moh.nsf/bf38a2d2e174417cc225782600313992/3B7C3521A6E9A1BBC2257CF30028391C/$file/Προσυμπτωματικός%20έλεγχος%20για%20καρκίνο%20του%20προστάτη.pdf Click here to access].